Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

Nature Medicine

Volumn 2, Issue 4, 1996, Pages 418-423

  Isaka, Yoshitaka ^a   Brees, Douglas K ^a   Ikegaya, Kazuko ^a   Kaneda, Yasufumi ^b   Imai, Enyu ^c   Noble, Nancy A ^a   Border, Wayne A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; EXTRACELLULAR MATRIX; GENE THERAPY; GLOMERULONEPHRITIS; KIDNEY FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SKELETAL MUSCLE;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLOMERULONEPHRITIS; KIDNEY; MUSCLE, SKELETAL; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0029905441     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0496-418     Document Type: Article

References (33)

1. Border, W.A. & Noble, N.A. Transforming growth factor-β in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292 (1994).
2. Sporn, M.B. & Roberts, A.B. Transforming growth factor β: Recent progress and new challenges. J. Cell Biol 119, 1017-1921 (1992).
3. Border, W.A. & Noble, N.A. Fibrosis linked to TGF-β in yet another disease. J. Clin. Invest. 6, 665 (1995).
4. Yamaguchi, Y., Mann, D.M. & Ruoslahti, E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346, 281-284 (1990).
5. Border, W.A. et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360, 361-364 (1992).
6. Blau, H.M. & Springer, M.L. Gene therapy - a novel form of drug delivery. N. Engl. J. Med. 333, 1294-1297 (1995).
7. Blau, H.M. & Springer, M.L. Muscle-mediated gene therapy. N. Engl. J. Med. 333, 1294-1556 (1995).
8. Marshall, E. Gene therapy's growing pains. Science 269, 1050-1055 (1995).
9. Touchette, N. Gene therapy: Not ready for prime time. Nature Med. 2, 7-8 (1996).
10. Yamamoto, T. et al. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 49, 461-169 (1996).
11. Wolff, J.A. et al. Direct gene transfer into mouse muscle In vivo. Science 247, 1465-1468 (1990).
12. Danko, I. & Wolff, J.A. Direct gene transfer into muscle. Vaccine 12,1499-1502 (1994).
13. Tripathy, S.K., Goldwasser, E., Lu, M.-M., Barr, E. & Leiden, J.M. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci USA 91, 11557-11561 (1994).
14. Raz, A.A. et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90, 4523-4527 (1993).
15. Kato, K., Kaneda, Y., Sakurai, M. Nakanishi, M. & Okada, Y. Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats. J. Biol. Chem. 266, 22071-22074 (1991).
16. Kaneda, Y., Iwai, K. & Uchida, T. Introduction and expression of the human in-sulin gene in adult rat liver. J. Biol. Chem. 264, 12126-12129 (1989).
17. Kaneda, Y., Iwai, K. & Uchida, T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243, 375-378 (1989).
18. Noble, N.A., Harper, J.R. & Border, W.A. In vivo interactions of TGF-β and extracellular matrix. Prog. Growth Factor Res. 4, 369-382 (1992).
19. Van Den Born, J. et al. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: Characterization and immunohistological application in human tissues. J. Histochem. Cytochem. 42, 89-102 (1994).
20. Felgner, P.L. Genes in a bottle. Lab. Invest. 68, 1-3 (1993).
21. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B. & Ruoslahti, E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 336, 371-374 (1990).
22. Kähäri, V.-M., Larjava, H. & Uitto, J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. J. Biol Chem. 266, 10608-10615 (1991).
23. Ruoslahti, E. & Yamaguchi, Y. Proteoglycans as modulators of growth factor activities. Cell 64, 867-869 (1991).
24. Border, W.A. & Noble, N.A. Targeting TGF-β for treatment of disease. Nature Med. 1, 1000-1001 (1995).
25. Dreher, K.L., Asundi, V., Matzura, D. & Cowan, K. Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall. Eur. J. Cell Biol. 53, 296-304 (1990).
26. Asundi, V. & Dreher, K.L. Molecular characterization of vascular smooth muscle decorin: Deduced core protein structure and regulation of gene expression. Eur. J. Cell Biol. 59, 314-321 (1992).
27. Niwa, H., Yammamura, K. & Miyazaki, J. Efficient selection for high expression transfectants with a novel eukaryotic vector. Gene 108, 193-199 (1991).
28. Isaka, Y. et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor into the rat kidney. /. Clin. Invest. 92, 2597-2601 (1993).
29. Takeshita, S. et al. Increased gene expression after liposome-mediated arterial gene transfer associated with intimai smooth muscle cell proliferation. J. Clin. Invest. 93, 652-661 (1994).
30. Okuda, S., Languino, L.R., Ruoslahti, E. & Border, W.A. Elevated expression of transforming growth factor-β and proteoglycan production In experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest. 86, 453-462 (1990).
31. Yamamoto, T, Noble, N.A., Miller, D.E. & Border, W.A. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 45, 916-927 (1994).
32. Derynck, R., Jarret, J.A., Chen, E.Y. & Goeddel D.V. The murine transforming growth factor-β precursor. J. Biol Client. 261, 4377-4379 (1986).
33. Fort, P. et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13, 1431-1443 (1985).